SAP vs SERA
SAP (SAP) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
SAP (SAP) common stock.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
SAP does not have a complete income-statement cache yet.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
SAP currently screens at market cap $0. SERA currently screens at market cap $89.1M.
Not investment advice. Open the SAP and SERA stock pages for the full models.
Not investment advice.